IBDEI0ES ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6462,0)
 ;;=I63.9^^43^401^5
 ;;^UTILITY(U,$J,358.3,6462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6462,1,3,0)
 ;;=3^Cerebral Infarction w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6462,1,4,0)
 ;;=4^I63.9
 ;;^UTILITY(U,$J,358.3,6462,2)
 ;;=^5007355^F01.51
 ;;^UTILITY(U,$J,358.3,6463,0)
 ;;=I65.9^^43^401^25
 ;;^UTILITY(U,$J,358.3,6463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6463,1,3,0)
 ;;=3^Occlusion/Stenosis of Precerebral Artery w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6463,1,4,0)
 ;;=4^I65.9
 ;;^UTILITY(U,$J,358.3,6463,2)
 ;;=^269751^F01.50
 ;;^UTILITY(U,$J,358.3,6464,0)
 ;;=I65.9^^43^401^26
 ;;^UTILITY(U,$J,358.3,6464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6464,1,3,0)
 ;;=3^Occlusion/Stenosis of Precerebral Artery w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6464,1,4,0)
 ;;=4^I65.9
 ;;^UTILITY(U,$J,358.3,6464,2)
 ;;=^269751^F01.51
 ;;^UTILITY(U,$J,358.3,6465,0)
 ;;=I66.9^^43^401^23
 ;;^UTILITY(U,$J,358.3,6465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6465,1,3,0)
 ;;=3^Occlusion/Stenosis of Cerebral Artery w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6465,1,4,0)
 ;;=4^I66.9
 ;;^UTILITY(U,$J,358.3,6465,2)
 ;;=^5007379^F01.50
 ;;^UTILITY(U,$J,358.3,6466,0)
 ;;=I66.9^^43^401^24
 ;;^UTILITY(U,$J,358.3,6466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6466,1,3,0)
 ;;=3^Occlusion/Stenosis of Cerebral Artery w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6466,1,4,0)
 ;;=4^I66.9
 ;;^UTILITY(U,$J,358.3,6466,2)
 ;;=^5007379^F01.51
 ;;^UTILITY(U,$J,358.3,6467,0)
 ;;=I67.9^^43^401^8
 ;;^UTILITY(U,$J,358.3,6467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6467,1,3,0)
 ;;=3^Cerebrovascular Disease w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6467,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,6467,2)
 ;;=^5007389^F01.50
 ;;^UTILITY(U,$J,358.3,6468,0)
 ;;=I67.9^^43^401^7
 ;;^UTILITY(U,$J,358.3,6468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6468,1,3,0)
 ;;=3^Cerebrovascular Disease w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,6468,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,6468,2)
 ;;=^5007389^F01.51
 ;;^UTILITY(U,$J,358.3,6469,0)
 ;;=I68.8^^43^401^9
 ;;^UTILITY(U,$J,358.3,6469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6469,1,3,0)
 ;;=3^Cerebrovascular Disorder in Oth Diseases w/o Behavioral Disturbance NEC
 ;;^UTILITY(U,$J,358.3,6469,1,4,0)
 ;;=4^I68.8
 ;;^UTILITY(U,$J,358.3,6469,2)
 ;;=^5007392^F01.50
 ;;^UTILITY(U,$J,358.3,6470,0)
 ;;=I68.8^^43^401^10
 ;;^UTILITY(U,$J,358.3,6470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6470,1,3,0)
 ;;=3^Cerebrovascular Disorder in Oth Diseases w/ Behavioral Disturbance NEC
 ;;^UTILITY(U,$J,358.3,6470,1,4,0)
 ;;=4^I68.8
 ;;^UTILITY(U,$J,358.3,6470,2)
 ;;=^5007392^F01.51
 ;;^UTILITY(U,$J,358.3,6471,0)
 ;;=I69.990^^43^401^1
 ;;^UTILITY(U,$J,358.3,6471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6471,1,3,0)
 ;;=3^Apraxia Following Cerebrovascular Disease w/o Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,6471,1,4,0)
 ;;=4^I69.990
 ;;^UTILITY(U,$J,358.3,6471,2)
 ;;=^5007568^F01.50
 ;;^UTILITY(U,$J,358.3,6472,0)
 ;;=I69.990^^43^401^2
 ;;^UTILITY(U,$J,358.3,6472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6472,1,3,0)
 ;;=3^Apraxia Following Cerebrovascular Disease w/ Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,6472,1,4,0)
 ;;=4^I69.990
 ;;^UTILITY(U,$J,358.3,6472,2)
 ;;=^5007568^F01.51
 ;;^UTILITY(U,$J,358.3,6473,0)
 ;;=I69.991^^43^401^11
 ;;^UTILITY(U,$J,358.3,6473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6473,1,3,0)
 ;;=3^Dysphagia Following Cerebrovascular Disease w/ Behavioral Disturbance
